Dr. Mary K. Dean, MD

Dr. Dean practices at Quincy Medical Group (Maine St) in Quincy, Illinois.

Dr. Dean's NPI, 1407266745, was assigned on May 7, 2014. Dr. Dean graduated from LSU Health Shreveport School of Medicine in 2014. Dr. Dean holds Texas license S6821.

Dr. Dean's primary practice is Quincy Medical Group (Maine St), at 1025 Maine Street, Quincy, IL 62301. The practice phone is (217) 222-6550.

Dr. Dean's primary practice is Quincy Medical Group (Maine St) in Quincy, Illinois. The medical group on file is Quincy Medical Group. Dmand AI also links Dr. Dean to 2 more medical groups and 1 ambulatory surgery center, each named with a free account. Dr. Dean's employer is on file too: a rural health clinic (rhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Dean is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Dean's licenses on file in 4 states: Texas, Illinois, Tennessee and South Carolina.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Dean treats.

CMS data shows 344 Medicare services from Dr. Dean across 8 procedure codes in 2023, for 13 Medicare patients. Medicare paid $21,877 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Dr. Dean in 2024. The largest group is 85 and over, with 0 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 73, with 63% women.

In 2024, Dr. Dean wrote 28 Medicare Part D claims for 23 patients. 89% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $232 in total drug cost. In 2022, CMS named 45 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dean for performance year 2024, reported through an alternative payment model (APM). Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Dean in 2018. 2018 was the busiest year, with 2. Dr. Dean's most frequent co-authors are Awad Ahmed, MD, Curtiland Deville, MD and Emma Brey Holliday, MD.

CMS Open Payments shows 5 general payments to Dr. Dean from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Iovance Biotherapeutics, Inc. paid the most, $145.

Dr. Dean graduated from LSU Health Shreveport School of Medicine in 2014.

Dr. Dean is in network with 17 carriers, including Elevance, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.